Published in Nature on December 09, 1999
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature (2010) 5.01
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J (2007) 4.66
Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol (2000) 3.97
Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A (2003) 3.85
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. EMBO J (2008) 2.95
Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron (2008) 2.88
An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature (2012) 2.67
Negative regulation of Vps34 by Cdk mediated phosphorylation. Mol Cell (2010) 2.57
Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat Neurosci (2007) 2.56
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics (2008) 2.11
Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci (2013) 2.05
Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol (2008) 1.93
Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J Neurosci (2010) 1.93
Cdk5 regulates accurate maturation of newborn granule cells in the adult hippocampus. PLoS Biol (2008) 1.92
Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet (2010) 1.90
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2003) 1.87
Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci U S A (2001) 1.73
Genetic modifiers of tauopathy in Drosophila. Genetics (2003) 1.70
Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Curr Med Chem (2008) 1.64
Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons. Cell Cycle (2012) 1.62
Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron (2008) 1.59
Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci U S A (2000) 1.58
Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.57
Neuronal activity regulates phosphorylation-dependent surface delivery of G protein-activated inwardly rectifying potassium channels. Proc Natl Acad Sci U S A (2008) 1.53
Regulation of the interaction between PIPKI gamma and talin by proline-directed protein kinases. J Cell Biol (2005) 1.47
Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci U S A (2000) 1.45
Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann N Y Acad Sci (2009) 1.44
Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One (2010) 1.41
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther (2010) 1.39
Activation of mislocalized opsin kills rod cells: a novel mechanism for rod cell death in retinal disease. Proc Natl Acad Sci U S A (2002) 1.37
A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death. EMBO J (2006) 1.37
An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol (2008) 1.36
Cyclin-dependent kinase 5 activity regulates pain signaling. Proc Natl Acad Sci U S A (2006) 1.34
Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc Natl Acad Sci U S A (2001) 1.34
Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. J Biol Chem (2006) 1.33
Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol (2002) 1.32
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci U S A (2008) 1.31
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. PLoS One (2011) 1.29
Ras and Rap signaling in synaptic plasticity and mental disorders. Neuroscientist (2010) 1.29
WAVE1 controls neuronal activity-induced mitochondrial distribution in dendritic spines. Proc Natl Acad Sci U S A (2008) 1.28
Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc Natl Acad Sci U S A (2003) 1.27
Calcium signaling in neurodegeneration. Mol Neurodegener (2009) 1.27
Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. EMBO J (2008) 1.26
A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J (2004) 1.26
Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol (2003) 1.24
Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice. J Neurosci (2010) 1.23
S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide. Proc Natl Acad Sci U S A (2011) 1.21
Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J Neurosci (2010) 1.21
Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev (2005) 1.19
CDK5 and MEKK1 mediate pro-apoptotic signalling following endoplasmic reticulum stress in an autosomal dominant retinitis pigmentosa model. Nat Cell Biol (2012) 1.17
A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein. J Biol Chem (2005) 1.16
Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell (2006) 1.16
Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. J Biol Chem (2011) 1.15
Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci (2014) 1.15
Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J (2002) 1.13
Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J Neurosci (2008) 1.13
The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death. Nat Cell Biol (2010) 1.12
HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol Neurodegener (2013) 1.12
Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am J Pathol (2004) 1.12
BAR the door: cancer suppression by amphiphysin-like genes. Biochim Biophys Acta (2008) 1.12
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation. J Biol Chem (2010) 1.11
A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J Neurosci (2011) 1.10
Oxidative stress in neurodegeneration. Adv Pharmacol Sci (2011) 1.09
TPPP/p25 promotes tubulin assemblies and blocks mitotic spindle formation. Proc Natl Acad Sci U S A (2003) 1.09
Calpain regulation of AMPA receptor channels in cortical pyramidal neurons. J Physiol (2007) 1.09
Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Biol Chem (2010) 1.08
Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology. Am J Pathol (2004) 1.08
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease. Arch Med Res (2012) 1.08
Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease. Mol Biol Cell (2008) 1.07
Cdk5 nuclear localization is p27-dependent in nerve cells: implications for cell cycle suppression and caspase-3 activation. J Biol Chem (2010) 1.06
Emerging role of protein-protein transnitrosylation in cell signaling pathways. Antioxid Redox Signal (2012) 1.06
Cyclin-dependent kinase 5 regulates the polarized trafficking of neuropeptide-containing dense-core vesicles in Caenorhabditis elegans motor neurons. J Neurosci (2012) 1.05
No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro. Proc Natl Acad Sci U S A (2010) 1.05
Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. BMC Cell Biol (2006) 1.04
Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons. Mol Biol Cell (2012) 1.04
Molecular pathology of neuro-AIDS (CNS-HIV). Int J Mol Sci (2009) 1.04
A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J (2012) 1.03
Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation. J Biol Chem (2011) 1.03
Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J Neurochem (2009) 1.03
Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE. Mol Cell Proteomics (2010) 1.03
Microglia in Alzheimer's Disease: It's All About Context. Int J Alzheimers Dis (2012) 1.02
The amyloid-beta precursor protein is phosphorylated via distinct pathways during differentiation, mitosis, stress, and degeneration. Mol Biol Cell (2007) 1.02
Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice. J Neuropathol Exp Neurol (2012) 1.02
Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease? Future Neurol (2009) 1.02
COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo. Neurogenetics (2009) 1.01
Surgical incision-induced nociception causes cognitive impairment and reduction in synaptic NMDA receptor 2B in mice. J Neurosci (2013) 1.01
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Clin Cancer Res (2011) 1.00
Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem J (2001) 1.00
Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects. Proc Natl Acad Sci U S A (2004) 1.00
Competition for microtubule-binding with dual expression of tau missense and splice isoforms. Mol Biol Cell (2001) 1.00
Activity-dependent p25 generation regulates synaptic plasticity and Aβ-induced cognitive impairment. Cell (2014) 1.00
Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD. Parkinsons Dis (2011) 0.99
Regulation of N-type voltage-gated calcium channels and presynaptic function by cyclin-dependent kinase 5. Neuron (2012) 0.99
MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease. EMBO J (2014) 0.99
Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors. Cancers (Basel) (2015) 0.99
Tau, prions and Aβ: the triad of neurodegeneration. Acta Neuropathol (2010) 0.99
p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity. Proc Natl Acad Sci U S A (2012) 0.98
Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells. BMC Biochem (2010) 0.97
Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. Cell Death Differ (2011) 0.97
Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci (2014) 0.97
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature (2000) 5.83
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (1994) 5.34
A decade of CDK5. Nat Rev Mol Cell Biol (2001) 5.24
Neuropathological findings in the brain of Karen Ann Quinlan. The role of the thalamus in the persistent vegetative state. N Engl J Med (1994) 5.08
A family of human cdc2-related protein kinases. EMBO J (1992) 4.96
A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell (1998) 4.78
A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol (1996) 4.61
Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell (1995) 4.48
Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature (2000) 4.31
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature (1999) 3.50
NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron (2000) 3.45
Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron (1997) 2.96
Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron (2000) 2.82
Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nat Cell Biol (2000) 2.81
Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70
Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature (1998) 2.59
The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev (1996) 2.59
Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature (1995) 2.21
Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13
The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature (1998) 2.01
Defective embryonic neurogenesis in Ku-deficient but not DNA-dependent protein kinase catalytic subunit-deficient mice. Proc Natl Acad Sci U S A (2000) 1.90
p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci (2001) 1.87
Disposal of therapeutic 131I waste using a multiple holding tank system. Health Phys (1998) 1.72
Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Chem Biol (2000) 1.71
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem (1998) 1.63
Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A (1987) 1.63
A defect in nurturing in mice lacking the immediate early gene fosB. Cell (1996) 1.63
Structure and regulation of the CDK5-p25(nck5a) complex. Mol Cell (2001) 1.57
Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest (1996) 1.43
The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene (1997) 1.40
Solitary caecal ulcer syndrome, a benign condition which mimics the CT appearance of caecal carcinoma. Clin Radiol (1999) 1.38
Idiopathic eruptive macular pigmentation: report of five patients. Pediatr Dermatol (1996) 1.35
Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J Biol Chem (2001) 1.32
Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2. J Biol Chem (2000) 1.31
Diffuse Lewy body disease and progressive dementia. Neurology (1988) 1.31
Cdk5 on the brain. Cell Growth Differ (2001) 1.21
Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci U S A (1999) 1.18
The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. Proc Natl Acad Sci U S A (1996) 1.15
Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts. Br J Cancer (1994) 1.15
Increased rate of peripheral nerve regeneration using bioresorbable nerve guides and a laminin-containing gel. Exp Neurol (1985) 1.12
The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev (1997) 1.09
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase. Proc Natl Acad Sci U S A (1999) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J Comp Neurol (1998) 1.07
Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures. J Neurosci (2001) 1.07
Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr Biol (2000) 1.06
Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J Neuroendocrinol (2004) 1.05
Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J Clin Invest (2000) 1.04
Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer (1995) 1.04
Insulin-like growth factor II affects the appearance and glycogen content of glycogen cells in the murine placenta. Endocrinology (1996) 1.03
The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol (1992) 1.01
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99
Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98
Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg (1993) 0.98
Progressive multifocal leukoencephalopathy associated with mycophenolate mofetil treatment in a woman with lupus and CD4+ T-lymphocyte deficiency. Lupus (2011) 0.98
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97
Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency. Proc Natl Acad Sci U S A (2000) 0.97
Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Cell Growth Differ (1996) 0.95
Localization of theta alloantigens in mouse brain by immunofluroescence and cytotoxic inhibition. Brain Res (1971) 0.95
A pancreatic endocrine tumor arising within a serous cystadenoma of the pancreas. Am J Surg Pathol (1996) 0.95
Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest (2001) 0.94
Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse. J Neurocytol (1997) 0.93
Peripheral nerve regeneration with entubulation repair: comparison of biodegradeable nerve guides versus polyethylene tubes and the effects of a laminin-containing gel. Exp Neurol (1987) 0.92
Bell-shaped nuclei dividing by symmetrical and asymmetrical nuclear fission have qualities of stem cells in human colonic embryogenesis and carcinogenesis. Cancer Genet Cytogenet (2006) 0.92
Case report of unusual leukoencephalopathy preceding primary CNS lymphoma. J Neurol Neurosurg Psychiatry (1998) 0.92
The early effect of pelvic floor muscle exercise after transurethral prostatectomy. J Urol (1998) 0.91
Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J Neurochem (1996) 0.91
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91
Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells. J Cell Physiol (2001) 0.90
Chromosomal assignment of human genomic NotI restriction fragments in a two-dimensional electrophoresis profile. Genomics (1996) 0.90
Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy. Phys Rev Lett (2011) 0.90
Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development. Am J Physiol (1995) 0.89
The systemic pathology of Venezuelan equine encephalitis virus infection in humans. Am J Trop Med Hyg (1985) 0.89
Variation of electron beam uniformity with beam angulation and scatterer position for total skin irradiation with the Stanford technique. Int J Radiat Oncol Biol Phys (1995) 0.88
Callosal axon guidance defects in p35(-/-) mice. J Comp Neurol (1999) 0.88
Backbone 1H, 15N, and 13C resonance assignments of inhibitor-2 -- a protein inhibitor of protein phosphatase-1. J Biomol NMR (2000) 0.88
Verrucous carcinoma of the foot: a case report. J Orthop Surg (Hong Kong) (2008) 0.88
The role of the p35/cdk5 kinase in cortical development. Results Probl Cell Differ (2000) 0.88
Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J Neurosci (2001) 0.87
Cyclin E-p27 opposition and regulation of the G1 phase of the cell cycle in the murine neocortical PVE: a quantitative analysis of mRNA in situ hybridization. Cereb Cortex (1999) 0.87
Synaptic localization of p39, a neuronal activator of cdk5. Neuroreport (2000) 0.87
The cyclin-dependent kinase family. Cold Spring Harb Symp Quant Biol (1991) 0.87
Measurement of the B(+) production cross section in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2011) 0.86
Search for pair production of second-generation scalar leptoquarks in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.86
An in vivo model to quantify motor and sensory peripheral nerve regeneration using bioresorbable nerve guide tubes. Brain Res (1985) 0.85
Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems. Eur J Clin Microbiol Infect Dis (2012) 0.85
Search for three-jet resonances in pp collisions at square root(s)=7 TeV. Phys Rev Lett (2011) 0.85
Measurement of the B0 production cross section in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2011) 0.85
Bloodstream infections caused by IMP-8-producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-β-lactamases? Eur J Clin Microbiol Infect Dis (2012) 0.85
Genetic immunization with the free human chorionic gonadotropin beta subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice. Lab Invest (1997) 0.84
Expression and imprinting of the insulin-like growth factor II gene in neonatal mouse cerebellum. J Neurosci Res (1997) 0.84